BG
UTHR icon

BlackRock Group’s United Therapeutics UTHR Stock Holding History

BlackRock Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$33.7M Sell
235,175
-13,329
-5% -$1.7M 0.02% 680
2016
Q3 		$29.3M Buy
248,504
+11,789
+5% +$1.42M 0.01% 706
2016
Q2 		$25.1M Sell
236,715
-18,256
-7% -$2.04M 0.01% 730
2016
Q1 		$28.4M Sell
254,971
-68,653
-21% -$8.69M 0.02% 715
2015
Q4 		$50.7M Buy
323,624
+74,087
+30% +$10.8M 0.03% 576
2015
Q3 		$32.7M Buy
249,537
+15,686
+7% +$2.52M 0.02% 671
2015
Q2 		$40.7M Buy
233,851
+116,221
+99% +$20.9M 0.02% 654
2015
Q1 		$20.3M Sell
117,630
-4,900
-4% -$747K 0.01% 807
2014
Q4 		$15.9M Sell
122,530
-9,665
-7% -$1.25M 0.01% 853
2014
Q3 		$17M Sell
132,195
-15,674
-11% -$1.62M 0.01% 833
2014
Q2 		$13.1M Sell
147,869
-34,850
-19% -$3.35M 0.01% 882
2014
Q1 		$17.2M Buy
182,719
+9,963
+6% +$1.02M 0.01% 805
2013
Q4 		$19.5M Buy
172,756
+46,137
+36% +$4.16M 0.01% 770
2013
Q3 		$9.98M Buy
126,619
+63,678
+101% +$4.65M 0.01% 929
2013
Q2 		$4.14M Buy
+62,941
New +$4.05M ﹤0.01% 1029

Other funds holding UTHR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

BlackRock Group's UTHR Position: Q4 2016 in Review

BlackRock Group reduced its United Therapeutics (UTHR) stake by 5.4% in Q4 2016, selling an estimated $1.7M and leaving 235,175 shares worth $33.7M. The position accounts for 0.02% of the portfolio, ranked #680.

BlackRock Group first reported a position in UTHR in Q2 2013 and has held it in 15 quarters since. The position peaked at $50.7M in Q4 2015. 406 funds tracked by Wall St. Rank hold UTHR as of Q4 2016.

  • BlackRock Group held 235,175 shares of United Therapeutics worth $33.7M as of Q4 2016.
  • BlackRock Group sold 13,329 United Therapeutics shares in Q4 2016, an estimated $1.7M.
  • United Therapeutics made up 0.02% of BlackRock Group's portfolio in Q4 2016, its #680 holding.
  • BlackRock Group first reported a position in United Therapeutics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Group's United Therapeutics position peaked at $50.7M in Q4 2015.
  • 406 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.